Answers are grounded in this paper and cite their sources.
Tc-EDDA/HYNIC-TOC is an easily available and cheaper radionuclide that could be used for somatostatin-receptor-based imaging of neuroendocrine tumours (NETs). We aimed to evaluate the diagnostic performance of 99m Tc-EDDA/HYNIC-TOC compared to 111 In-DTPA-octreotide in patients (pts) with NETs. We performed a prospective diagnostic study including pts with biopsy-confirmed NET and at least one visible lesion at conventional imaging. Two independent nuclear medicine physicians evaluated pts who underwent 99m Tc and 111 In scans and images. The primary outcome was comparative diagnostic accuracy of 99m Tc and 111 In. Secondary outcomes include safety.
No takes yet. Share an insight, caveat, or question.
Moriguchi-Jeckel et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: